HomeORY • BME
add
Oryzon Genomics SA
Previous close
€2.83
Day range
€2.84 - €3.14
Year range
€1.40 - €3.69
Market cap
190.50M EUR
Avg Volume
1.40M
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.36M | -48.15% |
Operating expense | 1.86M | -61.21% |
Net income | -1.21M | 32.47% |
Net profit margin | -16.43 | -30.19% |
Earnings per share | -0.02 | 30.49% |
EBITDA | 5.24M | -43.04% |
Effective tax rate | 61.18% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.62M | -54.16% |
Total assets | 108.72M | 1.70% |
Total liabilities | 21.67M | -13.74% |
Total equity | 87.04M | — |
Shares outstanding | 64.37M | — |
Price to book | 2.10 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.21M | 32.47% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2000
Website
Employees
44
